Covid-19 impact: Government panel lists essential drugs that can run out
Posted by
www.biotecnika.org
A high-level government committee, which submitted its report to the
Department of Pharmaceuticals (DoP) last week, reviewed 54 drugs and
said that out of these, 34 have no alternative. Out of the 54, it
classified 32 as critical and essential, 15 as noncritical and
essential and seven drugs as essential.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/covid-19-impact-government-panel-lists-essential-drugs-that-can-run-out/articleshow/74449944.cms
Subscribe to:
Post Comments (Atom)
Post a Comment